ParadigMS e-learning: The role of Microglia in Multiple Sclerosis

ParadigMS Foundation

By ParadigMS Foundation

November 29, 2022

ParadigMS is finalising its first, self-paced and asynchronous e-learning. It will be a +2-hour e-learning on Microglia and we’ll submit it for EACMME accreditation.

Would you like to get notified once the e-learning is launched?

The e-learning on Microglia in MS aims to contribute to the continued medical education of neurologists in Europe and to the accessibility of medical information on the role of microglia in MS. 

A first part of the e-learning will provide learners a comprehensive overview of the innate immune cell pathobiology in MS and share the latest research findings in this evolving field. In a second part, the elearning will help learners understanding the basis of the use of PET and MRI imaging in detecting activated microglia in the CNS in MS in vivo.

Discover a new way of learning!

What are the learning outcomes?

At the end of the e-learning, learners will understand and be able to explain to a colleague or PwMS the innate immune cell pathobiology in MS. Learners will also be able to understand the basis of the use of PET and MRI imaging in detecting activated microglia in the CNS in MS in vivo. This will be helpful for advancing the utilization of these techniques for the benefit of MS patients.

E-learning sections

  • Immunology – developed by Prof. Ralph Linker, University of Regensburg, Germany
  • Neuroprotection & Remyelination – developed by Prof. Nikolaos Grigoriadis, Aristotle University of Thessaloniki, Greece
  • MRI – developed by Prof. Veronica Popescu, University MS Center Pelt–Hasselt , Belgium
  • OCT – developed by Prof. Celia Oreja-Guevara, University Hospital San Carlos Madrid, Spain
  • PET – developed by Prof. Laura Airas, University of Turku, Finland
  • High EfficacyTreatments – developed by Prof. Patrick Vermersch, University of Lille, France
  • Clinical Progression– developed by Prof. Carlo Pozzilli, University of Roma La Sapienza, Italy

    Stay tuned for more updates!

With thanks to our sponsor who supports this e-learning without any involvement in the elaboration of the presentations.

Educational slide decks
endorsed by experts

Minimum two MS experts collaborate to produce an educational slide deck. These slide decks are presented (live) to ParadigMS members, peer reviewed and updated.
The slide decks are published on the ParadigMS website “on behalf of ParadigMS”.

Consensus publications

Based on the slide decks, publications are produced. These publications are peer reviewed and published as consensus publications.

Regional and national educational events

Regional (fe: Scandinavian countries, Benelux, …) or national events where state-of-the-art science is transferred to general neurologists and other care givers (nurses, etc) that are confronted with MS in their day to day practice.

Web-based educational tools and resources

Webinars can complement the educational events.

Medical education (ME) programs

The educational slide decks, events and webinars can be important building blocks of accredited educational programs.

FAQs

Do subscriptions auto-renew?
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
What happens if I subscribe as a healthcare practitioner if I am not a healthcare practitioner?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
How can I cancel my trial or subscription?
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.

Terms and Conditions

All the Terms and Conditions of the ParadigMS Foundation Website can be downloaded here.

Subscribe to our bi-annual Newsletter

ParadigMS does not send eNewsletters that contain advertisements and we do not share your contact details with sponsors (unless we received your explicit consent)